Study of the Effects of Tribulus Terrestris on Sexuality in Postmenopausal Women
| Registry | NCT01407445 |
|---|---|
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional; randomized, parallel, masking: double, treatment |
| Enrollment | 60 (Actual) |
| Sponsor | Faculdade de Ciências Médicas da Santa Casa de São Paulo (Other); collaborators: Fundação de Amparo à Pesquisa do Estado de São Paulo |
| Conditions | Sexual Functions and Problems in the Adult |
| Interventions | Placebo, Tribulus terrestris (Drug) |
| Dates | start 2009-01-01, primary completion 2011-05-01, completion 2011-05-01, first posted 2011-08-02, last updated 2015-11-10 |
| Locations | 1 site in Brazil |
Related Papers Related Patents Related Grants Related Experts
All trials for Sexual Functions and Problems in the Adult All trials of Placebo All trials of Tribulus terrestris
Objective: To study the effects of Tribulus terrestris on sexuality in postmenopausal women.
Sexuality is an integral part of every personality, influence thoughts, feelings, actions, integrations, and therefore the physical and mental health. It is estimated that 43% of women have at least one complaint of sexual problem. Disorders of desire and arousal are among the most common problems found in gynecologic practice. Medicinal plants have been used for therapeutic purposes for thousands of years, and aphrodisiac properties described in several plants. Tribulus terrestris is a plant indigenous to India, recommended in the treatment of infertility, low libido and impotence, and its main active ingredient protodioscin (PTN).
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Placebo | Placebo comparator | Drug: Placebo | 1 tablet of placebo/ oral/ 3 times a day for three months |
| Tribulus terrestris | Active comparator | Drug: Tribulus terrestris | 1 tablet of 250mg/ oral/ 3 times a day for three months |
Sex: Female, ages: 40 Years to 70 Years
Inclusion Criteria: * Women past menopause, with full autonomy, at least one year of amenorrhea and FSH> 30 mIU / mL. * Sexually active * Partner is stable and without sexual difficulties * Carrier sexual abuse (desire, arousal, orgasm and dyspareunia) Exclusion Criteria: * Women on hormone therapy within the preceding 12 months * Women without sexual activity * With diabetes mellitus * Patients with cognitive impairment * Patients with hormone-dependent tumor * History of psychiatric illness * Patients with liver disease * Patients with kidney disease * Users of drugs with proven to decrease sexual desire * Cardivascular disease, renal disease.
| Facility | City | Country | Status |
|---|---|---|---|
| Santa Casa of Sao Paulo Medical School | São Paulo, São Paulo | Brazil |